A comprehensive review on indole-chalcone hybrid as promising scaffold with diverse therapeutic potential
Harshal Tavanoji1, Ganesh Latambale1, Kapil Juvale1
1Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai 400 056, India.
Abstract:
Indole-chalcone hybrids have emerged as a highly promising class of compounds in modern medicinal chemistry, owing to their unique dual pharmacophore structure that integrates the bioactive indole and chalcone units. Recent studies have highlighted these hybrids' diverse and potent pharmacological activities, including anticancer, antimicrobial, anti-inflammatory, antidiabetic, antiviral, and neuroprotective effects. The combination of the indole ring and chalcone scaffold, achieved through molecular hybridization, facilitates a synergistic mechanism of action, enabling these hybrids to modulate multiple biological pathways and thereby enhance their therapeutic potential. This review focuses on indole-chalcone hybrids' structure-activity relationship (SAR) to identify the key molecular determinants that contribute to their bioactivity. Furthermore, the multifunctional nature of these hybrids is discussed, offering promising prospects for developing novel, more effective therapeutic agents with optimized efficacy and reduced toxicity. By consolidating current findings, this review aims to provide a comprehensive resource to guide future research efforts and facilitate the continued exploration of indole-chalcone hybrids as versatile scaffolds in drug discovery.
More Related Videos
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists


